Cancer Center Basic Research Programs

The Basic Research program includes characterizing myeloma and tumor-specific T cells, identifying novel myeloma-associated antigens and better methods for immunotherapy, investigating the cross-talk between the tumor microenvironment and the immune system in malignancy, exploring immunotherapies using novel myeloma antigens and clinical trials.

Qing Yi, MD, PhD

Qing Yi, MD, PhD, is the associate director of Basic Research Programs, and professor of oncology in the Cancer Center at Houston Methodist. Learn more

Protein from multiple myeloma cells offers novel treatment approach

A research study by Qing Yi, MD, PhD, and colleagues showed that a protein derived from multiple myeloma cells promoted the immunosuppressive function of white blood cells, offering potential for multiple myeloma treatment. Learn more

Live Chat Available